Authors: DALQUEN P BASCHIERA B CHAFFARD R DIETERICH H FEICHTER GE KRAMER K TORHORST J

Citation: P. Dalquen et al., MIB-1 (KI-67) IMMUNOSTAINING OF BREAST-CANCER CELLS IN CYTOLOGIC SMEARS, Acta cytologica, 41(2), 1997, pp. 229-237

Authors: FEICHTER GE HABERTHUR F GOBAT S DALQUEN P

Citation: Ge. Feichter et al., BREAST CYTOLOGY - STATISTICAL-ANALYSIS AND CYTOHISTOLOGIC CORRELATIONS, Acta cytologica, 41(2), 1997, pp. 327-332

Authors: VONMINCKWITZ G KUHN W KAUFMANN M FEICHTER GE HEEP J SCHMID H BASTERT G

Citation: G. Vonminckwitz et al., PROGNOSTIC IMPORTANCE OF DNA-PLOIDY AND S-PHASE FRACTION IN ENDOMETRIAL CANCER, International journal of gynecological cancer, 4(4), 1994, pp. 250-256

Authors: BUCHHOLZ NP MOCH H FEICHTER GE SCHMID HP MIHATSCH MJ

Citation: Np. Buchholz et al., CLINICAL AND PATHOLOGICAL FEATURES OF HIGHLY MALIGNANT PROSTATIC CARCINOMAS WITH METASTASES TO THE PENIS, Urologia internationalis, 53(3), 1994, pp. 135-138

Authors: MOCH H TORHORST J DURMULLER U FEICHTER GE SAUTER G GUDAT F

Citation: H. Moch et al., COMPARATIVE-ANALYSIS OF THE EXPRESSION OF TENASCIN AND ESTABLISHED PROGNOSTIC FACTORS IN HUMAN BREAST-CANCER, Pathology research and practice, 189(5), 1993, pp. 510-514

Authors: HABERTHUR F FEICHTER GE TORHORST JKH

Citation: F. Haberthur et al., SARCOMAS OF THE BREAST - WHAT IS THE RELE VANCE OF IMMUNOHISTOCHEMISTRY AND FLOW-CYTOMETRY, Geburtshilfe und Frauenheilkunde, 53(11), 1993, pp. 811-813